Candida Urinary Tract Infections—Treatment
Open Access
- 15 May 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 52 (suppl_6), S457-S466
- https://doi.org/10.1093/cid/cir112
Abstract
In many instances a report from the clinical laboratory indicating candiduria represents colonization or procurement contamination of the specimen and not invasive candidiasis. Even if infection of the urinary tract by Candida species can be confirmed, antifungal therapy is not always warranted. Further investigation may reveal predisposing factors, which if corrected or treated, result in the resolution of the infection. For those with symptomatic urinary tract infections (UTIs), the choice of antifungal agent will depend upon the clinical status of the patient, the site of infection, and the pharmacokinetics and pharmacodynamics of the agent. Because of its safety, achievement of high concentrations in the urine, and availability in both an oral and intravenous formulation, fluconazole is preferred for the treatment of Candida UTIs. Flucytosine is concentrated in urine and has broad activity against Candida spp, but its use requires caution because of toxicity. Low-dose amphotericin B may be useful for Candida UTIs in selected patients. The role of echinocandins and azoles that do not achieve measurable concentrations in the urine is not clear. Small case series note some success, but failures have also occurred. Irrigation of the bladder with antifungal agents has limited utility. However, with fungus balls, irrigation of the renal pelvis through a nephrostomy tube can be useful in combination with systemic antifungal agents.Keywords
This publication has 99 references indexed in Scilit:
- Combination Flucytosine and High‐Dose Fluconazole Compared with Fluconazole Monotherapy for the Treatment of Cryptococcal Meningitis: A Randomized Trial in MalawiClinical Infectious Diseases, 2010
- Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility TestingClinical Microbiology Reviews, 2006
- Posaconazole Pharmacokinetics, Safety, and Tolerability in Subjects With Varying Degrees of Chronic Renal DiseaseThe Journal of Clinical Pharmacology, 2005
- SUCCESSFULLY TREATED RENAL FUNGAL BALL WITH CONTINUOUS IRRIGATION OF FLUCONAZOLEJournal of Urology, 2001
- Genitourinary fungal infections: a therapeutic conundrumExpert Opinion on Pharmacotherapy, 2001
- Re: Fluconazole Treatment in Torulopsis Glabrata Upper Urinary Tract Infection Causing Ureteral ObstructionJournal of Urology, 1995
- FluconazoleDrugs, 1990
- Candidal Epididymitis Treated with KetoconazoleNew England Journal of Medicine, 1988
- Fungus Balls of the Urinary TractSouthern Medical Journal, 1979